Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal- pituitary axis activity or hyperthermia

Journal of Neuroscience

Volumn 28, Issue 4, 2008, Pages 893-903

  Sajdyk, Tammy J ^a   Johnson, Philip L ^a   Leitermann, Randy J ^c   Fitz, Stephanie D ^a   Dietrich, Amy ^a   Morin, Michelle ^b   Gehlert, Donald R ^b   Urban, Janice H ^c   Shekhar, Anantha ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Amygdala; Anxiety; Anxiolytic; Autonomic; BNST; CRF; CRH; Hypothalamus; Neuropeptide; NPY; RAPHE; Septum

Indexed keywords

CALCINEURIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HYPERTHERMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL FUNCTION; NERVE CELL; NERVE CELL PLASTICITY; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SOCIAL INTERACTION; STRESS; STRESS RESILIENCE;

AMYGDALA; ANIMALS; FEVER; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEUROPEPTIDE Y; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; TIME;

EID: 38549123307     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0659-07.2008     Document Type: Article

References (53)

1. Bale TL, Vale WW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557.
2. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL (1995) Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6:215-222.
3. Currie PJ, Coscina DV (1995) Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus. Peptides 16:599-604.
4. Davis M (1993) Pharmacological analysis of fear-potentiated startle. Braz J Med Biol Res 26:235-260.
5. Davis M (1994) The role of the amygdala in emotional learning. Int Rev Neurobiol 36:225-266.
6. Davis M, Walker DL, Lee Y (1997) Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Ann NY Acad Sci 821:305-331.
7. Felies M, von Horsten S, Pabst R, Nave H (2004) Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats. J Physiol (Lond) 561:245-252.
8. Gamber KM, Macarthur H, Westfall TC (2005) Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 49:646-652.
9. Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ (2003) The effects of chronic treatment with the mood stabilizers valporic acid and lithium on corticotropin-releasing factor neuronal systems. J Phamacol Exp Ther 305:434-439.
10. Grillon C, Southwick SM, Charney DS (1996) The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry 1:278-297.
11. Gutman AR, Chatwal JP, Davis M (2006) Neuropeptide Y modulation of startle. Soc Neurosci Abstr 32:67.9.
12. Heilig M (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59:201-205.
13. Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38:213-224.
14. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT (1993) Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357-363.
15. Herman JP, Cullinan WE, Ziegler DR, Tasker JG (2002) Role of the paraventricular nucleus microenvironment in stress integration. Eur J Neurosci 16:381-385.
16. Insel TR (1992) Oxytocin-a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 17:3-35.
17. Johnson PL, Hollis JH, Moratalla R, Lightman SL, Lowry CA (2005) Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats. J Psychopharmacol 19:327-341.
18. Kash TL, Winder DG (2006) Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51:1013-1022.
19. Kask A, Rago L, Harro J (1998) Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 788:345-348.
20. Kask A, Nguyen HP, Pabst R, Von Horsten S (2001) Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience 104:799-806.
21. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R (2002) The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26:259 -283.
22. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, Hollenberg AN, Friedman JM, Elmquist JK (2005) Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 482:217-243.
23. Koob GF (1999) Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46:1167-1180.
24. Koolhaas JM, Everts H, de Ruiter AJ, de Boer SF, Bohus B (1998) Coping with stress in rats and mice: differential peptidergic modulation of the amygdala-lateral septum complex. Prog Brain Res 119:437-448.
25. Kopp J, Xu ZQ, Zhang X, Pedrazzini T, Herzog H, Kresse A, Wong H, Walsh JH, Hokfelt T (2002) Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 111:443-532.
26. Kozak R, Richy S, Beck B (2005) Persistent alterations in neuropeptide Y release in the paraventricular nucleus of rats subjected to dietary manipulation during early life. Eur J Neurosci 21:2887-2892.
27. Lee Y, Schulkin J, Davis M (1994) Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF). Brain Res 666:93-98.
28. Lin CH, Lee CC, Gean PW (2003a) Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol 63:44 -52.
29. Lin CH, Yeh SH, Leu TH, Chang WC, Wang ST, Gean PW (2003b) Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23:1574-1579.
30. McDonald AJ (2003) Is there an amygdala and how far does it extend? An anatomical perspective. Ann NY Acad Sci 985:1-21.
31. McGaugh JL (2002) Memory consolidation and the amygdala: a systems perspective. Trends Neurosci 25:456.
32. Nakamura K, Matsumura K, Hubschle T, Nakamura Y, Hioki H, Fujiyama F, Boldogkoi Z, Konig M, Thiel HJ, Gerstberger R, Kobayashi S, Kaneko T (2004) Identification of sympathetic premotor neurons in medullary raphe regions mediating fever and other thermoregulatory functions. J Neurosci 24:5370-5380.
33. Nguyen NK, Keck ME, Hetzenauer A, Thoeringer CK, Wurst W, Deussing JM, Holsboer F, Muller MB, Singewald N (2006) Conditional CRF receptor 1 knock-out mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology (Berl) 188:374-385.
34. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, Ed 2. New York: Academic.
35. Petrov T, Krukoff TL, Jhamandas JH (1995) Convergent influence of the central nucleus of the amygdala and the paraventricular hypothalamic nucleus upon brainstem autonomic neurons as revealed by c-fos expression and anatomical tracing. J Neurosci Res 42:835-845.
36. Pitkanen A, Amaral DG (1991) Demonstration of projections from the lateral nucleus to the basal nucleus of the amygdala: a PHA-L study in the monkey. Experimental Brain Res 83:465-470.
37. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A (2004) Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 24:3471-3479.
38. Rostkowski AB, Urban JH (2006) Neuropeptide Y (NPY) Y1 receptor (Y1r) is expressed on both interneurons and projection neurons in the rat basolateral amygdala (BLA). In: Annual Society for Neuroscience Meeting. Atlanta, GA.
39. Sajdyk TJ, Vandergriff MG, Gehlert DR (1999a) Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368:143-147.
40. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A (1999b) Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behavioural Brain Res 100:207-215.
41. Sajdyk TJ, Schober DA, Gehlert DR (2002) Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 43:1165-1172.
42. Sajdyk TJ, Keim SR, Thielen SK, Fitz SD, Shekhar A (2003) Measurements of anxiety-like behavior following intravenous infusion of sodium lactate in primed rats. In: Current Protocols in Neuroscience, Supplement 24, Unit 9.17.
43. Sajdyk TJ, Shekhar A, Gehlert DR (2004) Interactions between NPY and CRF in the amygdala regulate emotionality. Neuropeptides 38:225-234.
44. Sajdyk TJ, Fitz SD, Shekhar A (2006) The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 9:21-28.
45. Savander V, Go CG, LeDoux JE, Pitkanen A (1995) Intrinsic connections of the rat amygdaloid complex: projections originating in the basal nucleus. J Comp Neurol 361:345-368.
46. Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG (2003) The amygdala, panic disorder, and cardiovascular responses. Ann NY Acad Sci 985:308-325.
47. Singewald N, Sharp T (2000) Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98:759-770.
48. Singewald N, Salchner P, Sharp T (2003) Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275-283.
49. Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE (2004) Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128:7-14.
50. Sun N, Roberts L, Cassell MD (1991) Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis. Brain Res Bull 27:651-662.
51. Wolak ML, deJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH (2003) Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464:285-311.
52. Yehuda R, Brand S, Yang RK (2006a) Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry 59:660-663.
53. Yehuda R, Flory JD, Southwick S, Charney DS (2006b) Developing an agenda for translational studies of resilience and vulnerability following trauma exposure. Ann NY Acad Sci 1071:379-396.